A novel 4-(1,3,4-thiadiazole-2-ylthio)pyrimidine derivative inhibits cell proliferation by suppressing the MEK/ERK signaling pathway in colorectal cancer
By: Weiwei Li, Zhifu Yang, Likun Ding, Ying Wang, Xian Zhao, Jian Jie Chu, Qing Ji, Minna Yao and Jingwen Wang
Authors
Weiwei Li
Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi’an, China
Zhifu Yang
Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi’an, China
Likun Ding
Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi’an, China
Ying Wang
Department of Pharmacy, The Second Affiliated Hospital of Xi’an Medical University, Xi’an, China
Xian Zhao
Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi’an, China
Jian Jie Chu
Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi’an, China
Qing Ji
Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi’an, China
Minna Yao
Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi’an, China
Jingwen Wang
Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi’an, China
Language: English
Page range: 489 - 502
Accepted on: Apr 18, 2023
Published on: Sep 14, 2023
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2023 Weiwei Li, Zhifu Yang, Likun Ding, Ying Wang, Xian Zhao, Jian Jie Chu, Qing Ji, Minna Yao, Jingwen Wang, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.